ResearcherInsermActive in the last 2 years

Dimitrios Papakonstantinou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6924-9846. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 1 paper

Papers 1

Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ctarc.2025.100939 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Florent Ginhoux · 1 shared paper, 2025 · strength 0.20
- Paper Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenoca… DOI 10.1016/j.ctarc.2025.100939 ↗
Camille Blériot · 1 shared paper, 2025 · strength 0.20
- Paper Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenoca… DOI 10.1016/j.ctarc.2025.100939 ↗
Antoine Hollebecque · 1 shared paper, 2025 · strength 0.20
- Paper Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenoca… DOI 10.1016/j.ctarc.2025.100939 ↗
Alice Boilève · 1 shared paper, 2025 · strength 0.20
- Paper Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenoca… DOI 10.1016/j.ctarc.2025.100939 ↗
Michel Pierre Ducreux · 1 shared paper, 2025 · strength 0.20
- Paper Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenoca… DOI 10.1016/j.ctarc.2025.100939 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.